- Market Capitalization, $K 225,582
- Shares Outstanding, K 26,200
- Annual Sales, $ 12,120 K
- Annual Income, $ -36,680 K
- 60-Month Beta 0.09
- Price/Sales 18.68
- Price/Cash Flow N/A
- Price/Book 3.00
|Period||Period Low||Period High||Performance|
| || |
-2.05 (-20.40%)since 08/20/21
| || |
-2.85 (-26.27%)since 06/18/21
/PRNewswire/ -- Virtual Investor Conferences® and today announced that the presentations from the & 9 Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com....
/PRNewswire/ -- (NASDAQ: CLVR), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced that their CEO, , will present live at VirtualInvestorConferences.com...
NEW YORK, NY / ACCESSWIRE / August 30, 2021 / Clever Leaves Holdings Inc. (Nasdaq:CLVR) ("Clever Leaves" or the "Company"), a leading multinational operator and licensed producer of pharmaceutical-grade...
(MENAFN - Investor Brand Network) NetworkNewsWire Editorial Coverage : In a move that many expect to make a significant impact on the cannabis sector, the Colombian government has approved exports of...
- Q2 2021 Revenue Increased 89% and Gross Profit Increased 157% Year-Over-Year -
/PRNewswire/ -- In a move that many expect to make a significant impact on the cannabis sector, the Colombian government has for medical and other industries; the pivotal move marks another step forward...
This project will be one of the first sponsored research partnerships under Clever Leaves' recently announced Project Change Lives Campaign, whereby the Company has pledged to contribute up to US $25 million...
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ("Clever Leaves" or the "Company"), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference...
The initiative is part of Project Change Lives; Clever Leaves' $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company's first funded study with a research institution...